INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
π’ Indaptus Therapeutics is trading 5% up today on a technical rebound after recent declines
Indaptus Therapeutics is trading 5% higher at $1.36 in a technical rebound following several days of sharp declines and profit-taking. β’ The move comes...
π΄ Indaptus Therapeutics is trading 10.4% down today after continued post-rally profit-taking
Indaptus Therapeutics is trading at $1.29 (-10.42%) as the stock faces a second day of sharp selling driven by post-rally profit-taking following a steep...
π΄ Indaptus Therapeutics is trading 5.6% down today on continued post-rally profit-taking
Indaptus Therapeutics is trading 5.6% down at $1.36 as traders continue to lock in gains following the stock's recent sharp rebound. β’ The decline follows a...
π΄ Indaptus Therapeutics is trading 13.5% down today on profit-taking after a multi-day rebound
Indaptus Therapeutics is trading 13.5% down at $1.57 as investors engage in profit-taking and short-term selling following a sharp multi-day rally. β’ The...
π΄ Indaptus Therapeutics is trading 5.8% down today on profit-taking after recent rebound
Indaptus Therapeutics is trading 5.8% down at $1.72 on profit-taking following a sharp multi-day rebound. β’ The stock's decline follows a period of...
π’ Indaptus Therapeutics is trading 6.6% up today on broader market rebound
Indaptus Therapeutics is trading at $1.94 (+6.6%) in pre-market sessions, recovering from yesterdayβs risk-off driven after-hours decline. β’ The upward move...
π΄ Indaptus Therapeutics is trading 7.1% down today amid thin after-hours liquidity and a broader risk-off backdrop
Indaptus Therapeutics is trading at $1.69 (-7.14%) in after-hours trading after closing the regular session at $1.82, with the move appearing to be driven by...
π’ Indaptus Therapeutics is trading 5.2% up today as it rebounds from a steep two-day selloff
Indaptus Therapeutics is trading at $1.82 (+5.20%) as the stock stages a volatile rebound following a steep two-day selloff. β’ The move appears to be a...
INDP Drops 33% From Last Week's Peak β Is the Pullback a Reset or a Red Flag for This Micro-Cap Biotech?
Shares of Indaptus Therapeutics tumbled another 14% to $1.75 on Tuesday, extending a punishing slide that has now erased roughly a third of the stock's value...
π΄ Indaptus Therapeutics is trading 11% down today as profit-taking extends multi-day slide
Indaptus Therapeutics is trading 11% down today at $1.75 as investors continue to lock in profits following a recent sharp rally. β’ The move extends a period...
π΄ Indaptus Therapeutics is trading 17.2% down today as Friday's selloff extends amid profit-taking
Indaptus Therapeutics is trading at $2.09 (17.2% down) today as early pre-market strength faded and Fridayβs selloff extended into the new week. β’ The decline...
π΄ Indaptus Therapeutics is trading 7.3% down today as pre-market gains reverse
Indaptus Therapeutics is trading at $2.42 (-7.28%) as the stock reverses its earlier pre-market rebound. β’ The decline follows a selloff on Friday, with the...
π’ Indaptus Therapeutics is trading 10% up today as it rebounds from Friday's pullback
Indaptus Therapeutics is trading at $2.87 (+10%) in pre-market, staging a recovery after shares fell approximately 5β7% during Friday's profit-taking...
π΄ Indaptus Therapeutics is trading 7.4% down today on profit-taking after recent gains
Indaptus Therapeutics is trading 7.4% down at $2.56 as the stock pulls back following several days of sharp gains earlier this week. β’ The move comes in the...
π΄ Indaptus Therapeutics is trading 6.1% down today with no clear catalyst
Indaptus Therapeutics is trading 6.1% down at $2.60 in pre-market sessions after several days of steady gains earlier this week. β’ There are no fresh...
π΄ Indaptus Therapeutics is trading 5.1% down today amid broader market weakness
Indaptus Therapeutics is trading 5.1% down at $2.40 today, appearing to track broader market volatility as the Nasdaq Composite declines 1.54%. β’ The move...
π΄ Indaptus Therapeutics is trading 10.1% down
Indaptus Therapeutics is trading at $2.54, down 10.1% from a comparison close of $2.82 during regular trading. This is a price-action follow-up, so a separate...
π΄ Indaptus Therapeutics is trading 6% down today as it consolidates after a recent rally
Indaptus Therapeutics is trading 6% down at $2.65 today, giving back a portion of its recent gains following a sharp move higher on July 15, 2026. * The stock...
π’ Indaptus Therapeutics is trading 10.5% up
Indaptus Therapeutics is trading at $2.91, up 10.5% from a comparison close of $2.63 during regular trading. This is a price-action follow-up, so a separate...
π’ Indaptus Therapeutics is trading 6.1% up today on broader risk-on sentiment
Indaptus Therapeutics is trading 6.1% up at $2.79 following several volatile sessions and a recent market rebound. β’ The move appears driven by broader...